Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 49

1.

Evaluation of the performance of Abbott m2000 and Roche COBAS Ampliprep/COBAS Taqman assays for HIV-1 viral load determination using dried blood spots and dried plasma spots in Kenya.

Zeh C, Ndiege K, Inzaule S, Achieng R, Williamson J, Chih-Wei Chang J, Ellenberger D, Nkengasong J.

PLoS One. 2017 Jun 16;12(6):e0179316. doi: 10.1371/journal.pone.0179316. eCollection 2017.

2.

Misdiagnosis of HIV treatment failure based on clinical and immunological criteria in Eastern and Central Kenya.

Joram SL, Paul G, Moses K, Stanley B, Isaac M, Allan G, Tom M, Lilian K, Mildred M.

BMC Infect Dis. 2017 Jun 2;17(1):383. doi: 10.1186/s12879-017-2487-5.

3.

Accuracy of WHO immunological criteria in identifying virological failure among HIV-infected adults on First line antiretroviral therapy in Mwanza, North-western Tanzania.

Gunda DW, Kidenya BR, Mshana SE, Kilonzo SB, Mpondo BC.

BMC Res Notes. 2017 Jan 17;10(1):45. doi: 10.1186/s13104-016-2334-6.

4.

Long-Term Outcomes on Antiretroviral Therapy in a Large Scale-Up Program in Nigeria.

Meloni ST, Chang CA, Eisen G, Jolayemi T, Banigbe B, Okonkwo PI, Kanki PJ.

PLoS One. 2016 Oct 20;11(10):e0164030. doi: 10.1371/journal.pone.0164030. eCollection 2016.

5.

Pre-treatment minority HIV-1 drug resistance mutations and long term virological outcomes: is prediction possible?

Mzingwane ML, Tiemessen CT, Richter KL, Mayaphi SH, Hunt G, Bowyer SM.

Virol J. 2016 Oct 12;13(1):170.

6.

Evaluation of Two Techniques for Viral Load Monitoring Using Dried Blood Spot in Routine Practice in Vietnam (French National Agency for AIDS and Hepatitis Research 12338).

Taieb F, Tram TH, Ho HT, Pham VA, Nguyen L, Pham BH, Tong LA, Tuaillon E, Delaporte E, Nguyen AT, Bui DD, Do N, Madec Y.

Open Forum Infect Dis. 2016 Jul 7;3(3):ofw142. eCollection 2016 Sep.

7.

Differences in virologic and immunologic response to antiretroviral therapy among HIV-1-infected infants and children.

Ásbjörnsdóttir KH, Hughes JP, Wamalwa D, Langat A, Slyker JA, Okinyi HM, Overbaugh J, Benki-Nugent S, Tapia K, Maleche-Obimbo E, Rowhani-Rahbar A, John-Stewart G.

AIDS. 2016 Nov 28;30(18):2835-2843.

PMID:
27603293
8.

Evaluating the utility of provider-recorded clinical status in the medical records of HIV-positive adults in a limited-resource setting.

Stonbraker S, Befus M, Nadal LL, Halpern M, Larson E.

Int J STD AIDS. 2017 Jun;28(7):685-692. doi: 10.1177/0956462416663990. Epub 2016 Aug 5.

9.

Positive Predictive Value of the WHO Clinical and Immunologic Criteria to Predict Viral Load Failure among Adults on First, or Second-Line Antiretroviral Therapy in Kenya.

Waruru A, Muttai H, Ng'ang'a L, Ackers M, Kim A, Miruka F, Erick O, Okonji J, Ayuaya T, Schwarcz S.

PLoS One. 2016 Jul 6;11(7):e0158881. doi: 10.1371/journal.pone.0158881. eCollection 2016.

10.

The Effect of Switching to Second-Line Antiretroviral Therapy on the Risk of Opportunistic Infections Among Patients Infected With Human Immunodeficiency Virus in Northern Tanzania.

Ramadhani HO, Bartlett JA, Thielman NM, Pence BW, Kimani SM, Maro VP, Mwako MS, Masaki LJ, Mmbando CE, Minja MG, Lirhunde ES, Miller WC.

Open Forum Infect Dis. 2016 Jan 29;3(1):ofw018. doi: 10.1093/ofid/ofw018. eCollection 2016 Jan.

11.

Building laboratory capacity to support HIV care in Nigeria: Harvard/APIN PEPFAR, 2004-2012.

Hamel DJ, Sankalé JL, Samuels JO, Sarr AD, Chaplin B, Ofuche E, Meloni ST, Okonkwo P, Kanki PJ.

Afr J Lab Med. 2015;4(1). pii: 190. Epub 2015 May 14.

12.

Viral load monitoring and antiretroviral treatment outcomes in a pediatric HIV cohort in Ghana.

Kukoyi O, Renner L, Powell J, Barry O, Prin M, Kusah J, Cong X, Paintsil E.

BMC Infect Dis. 2016 Feb 3;16:58. doi: 10.1186/s12879-016-1402-9.

13.

Can HIV reverse transcriptase activity assay be a low-cost alternative for viral load monitoring in resource-limited settings?

Gupta S, Palchaudhuri R, Neogi U, Srinivasa H, Ashorn P, De Costa A, Källander C, Shet A.

BMJ Open. 2016 Jan 27;6(1):e008795. doi: 10.1136/bmjopen-2015-008795.

14.

Outcome of patients on second line antiretroviral therapy under programmatic condition in India.

Chakravarty J, Sundar S, Chourasia A, Singh PN, Kurle S, Tripathy SP, Chaturbhuj DN, Rai M, Agarwal AK, Mishra RN, Paranjape RS.

BMC Infect Dis. 2015 Nov 14;15:517. doi: 10.1186/s12879-015-1270-8.

15.

Brief Report: Virologic Monitoring Can Be a Cost-Effective Strategy to Diagnose Treatment Failure on First-Line ART.

Vandormael AM, Boulware DR, Tanser FC, Bärnighausen TW, Stott KE, de Oliveira T.

J Acquir Immune Defic Syndr. 2016 Apr 1;71(4):462-6. doi: 10.1097/QAI.0000000000000870.

16.

The adherence-outcome relationship is not altered by diary-driven adjustments of microelectronic monitor data.

Eby J, Chapman J, Marukutira T, Anabwani G, Tshume O, Lepodisi O, Dipotso T, Mokete K, Gross R, Lowenthal E.

Pharmacoepidemiol Drug Saf. 2015 Dec;24(12):1313-20. doi: 10.1002/pds.3887. Epub 2015 Oct 12.

17.

Modelling the impact and cost-effectiveness of combination prevention amongst HIV serodiscordant couples in Nigeria.

Mitchell KM, Lépine A, Terris-Prestholt F, Torpey K, Khamofu H, Folayan MO, Musa J, Anenih J, Sagay AS, Alhassan E, Idoko J, Vickerman P.

AIDS. 2015 Sep 24;29(15):2035-44. doi: 10.1097/QAD.0000000000000798.

18.

The Impact of Different CD4 Cell-Count Monitoring and Switching Strategies on Mortality in HIV-Infected African Adults on Antiretroviral Therapy: An Application of Dynamic Marginal Structural Models.

Ford D, Robins JM, Petersen ML, Gibb DM, Gilks CF, Mugyenyi P, Grosskurth H, Hakim J, Katabira E, Babiker AG, Walker AS; DART Trial Team.

Am J Epidemiol. 2015 Oct 1;182(7):633-43. doi: 10.1093/aje/kwv083. Epub 2015 Aug 26.

19.

On the front line of HIV virological monitoring: barriers and facilitators from a provider perspective in resource-limited settings.

Rutstein SE, Golin CE, Wheeler SB, Kamwendo D, Hosseinipour MC, Weinberger M, Miller WC, Biddle AK, Soko A, Mkandawire M, Mwenda R, Sarr A, Gupta S, Mataya R.

AIDS Care. 2016;28(1):1-10. doi: 10.1080/09540121.2015.1058896. Epub 2015 Aug 17.

20.

Prevalence and Predictors of Immunological Failure among HIV Patients on HAART in Southern Ethiopia.

Yirdaw KD, Hattingh S.

PLoS One. 2015 May 11;10(5):e0125826. doi: 10.1371/journal.pone.0125826. eCollection 2015.

Supplemental Content

Support Center